IL166757A0 - A method of isolating cells - Google Patents

A method of isolating cells

Info

Publication number
IL166757A0
IL166757A0 IL16675702A IL16675702A IL166757A0 IL 166757 A0 IL166757 A0 IL 166757A0 IL 16675702 A IL16675702 A IL 16675702A IL 16675702 A IL16675702 A IL 16675702A IL 166757 A0 IL166757 A0 IL 166757A0
Authority
IL
Israel
Prior art keywords
cell lines
well
generating cell
cells
protein
Prior art date
Application number
IL16675702A
Other languages
English (en)
Original Assignee
Chromocell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chromocell Corp filed Critical Chromocell Corp
Publication of IL166757A0 publication Critical patent/IL166757A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL16675702A 1999-11-23 2002-08-28 A method of isolating cells IL166757A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16698799P 1999-11-23 1999-11-23
US09/718,448 US6692965B1 (en) 1999-11-23 2000-11-22 Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
PCT/US2002/027749 WO2004020625A1 (en) 1999-11-23 2002-08-28 SELECTION AND ISOLATION OF LIVING CELLS USING mRNA-BINDING PROBES

Publications (1)

Publication Number Publication Date
IL166757A0 true IL166757A0 (en) 2006-01-15

Family

ID=36640908

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16675702A IL166757A0 (en) 1999-11-23 2002-08-28 A method of isolating cells

Country Status (15)

Country Link
US (4) US6692965B1 (xx)
EP (2) EP2264165B1 (xx)
JP (1) JP4502808B2 (xx)
KR (1) KR101257500B1 (xx)
CN (1) CN1688693B (xx)
AT (1) ATE541924T1 (xx)
AU (1) AU2002332768A1 (xx)
CA (1) CA2496821C (xx)
DK (2) DK2264165T3 (xx)
ES (2) ES2379731T3 (xx)
IL (1) IL166757A0 (xx)
MX (1) MXPA05002192A (xx)
NZ (1) NZ538852A (xx)
PT (1) PT1546327E (xx)
WO (1) WO2004020625A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692965B1 (en) * 1999-11-23 2004-02-17 Chromocell Corporation Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
KR20150005720A (ko) * 2004-02-18 2015-01-14 크로모셀 코포레이션 신호 프로브를 이용하는 방법 및 물질
CA2667631C (en) 2006-10-10 2017-11-07 Miacom Diagnostics Gmbh Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
CN101611137A (zh) * 2006-11-30 2009-12-23 克罗莫塞尔公司 用于蛋白质生产的最优化的宿主细胞
US20080216185A1 (en) * 2007-01-19 2008-09-04 Invitrogen Corporation Compositions and Methods for Genetic Manipulation and Monitoring of Cell Lines
ES2391906T3 (es) * 2007-09-12 2012-11-30 Institut Pasteur Polinucleótido apto para un ensayo indicador basado en una sola célula para controlar los patrones de expresión génica con una resolución espacio-temporal elevada
US20100297674A1 (en) * 2008-01-22 2010-11-25 Chromocell Corporation NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM
US9534035B2 (en) * 2008-01-25 2017-01-03 Chromocell Corporation Cell lines expressing ENaC and methods using them
NZ586957A (en) * 2008-02-01 2014-03-28 Chromocell Corp Cell lines and methods for making and using them
EP2186827A1 (en) 2008-11-14 2010-05-19 HS LifeSciences Ltd. Surrogate marker directed cDNA cloning of selectively induced mRNAs
EP2391711B1 (en) * 2009-02-02 2015-04-08 Chromocell Corporation Novel cell lines and methods
WO2011014740A2 (en) 2009-07-31 2011-02-03 Chromocell Corporation Methods and composition for identifying and validating modulators of cell fate
US20120131701A1 (en) 2009-08-05 2012-05-24 Chromocell Corporation Improved plants, microbes, and organisms
CN103998933B (zh) 2011-10-20 2016-12-14 卓莫赛尔公司 鉴定调节苦味的化合物的测定
CN119655753A (zh) * 2012-12-14 2025-03-21 明德拉公司 用于检测和获取生物标志物的方法和装置
WO2014144991A1 (en) * 2013-03-15 2014-09-18 Chromocell Corporation Methods and materials using signaling probes
US9493742B2 (en) 2013-03-15 2016-11-15 Emory University Purification of cell mixtures using molecular beacons targeting cell specific RNA
WO2014151994A1 (en) 2013-03-15 2014-09-25 Kambiz Shekdar Genome editing using effector oligonucleotides for therapeutic treatment
CN105358983B (zh) 2013-04-24 2018-08-03 卓莫赛尔公司 用于鉴定调节苦味的化合物的测定
US20160177396A1 (en) * 2014-12-22 2016-06-23 Enzo Biochem, Inc. Comprehensive and comparative flow cytometry-based methods for identifying the state of a biological system
EP3612629A1 (en) 2017-04-18 2020-02-26 The Broad Institute, Inc. Compositions for detecting secretion and methods of use
WO2019210268A2 (en) 2018-04-27 2019-10-31 The Broad Institute, Inc. Sequencing-based proteomics
CN110819656B (zh) * 2019-11-11 2021-06-04 中国科学院上海高等研究院 一种基于同步光源的x-射线多色遗传标记探针及其制备方法以及应用
AU2021385427A1 (en) 2020-11-30 2023-06-29 Mindera Corporation Microneedle devices and methods, and skin condition assays

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0791659A3 (en) * 1989-11-13 1997-09-17 Children's Medical Center Corporation Antigen specific separation of nucleated fetal cells in non-invasive detection of fetal DNA
JPH07509136A (ja) * 1992-07-17 1995-10-12 バイシス，インク． インサイチュ（ｉｎ　ｓｉｔｕ）・ハイブリダイゼーションのための母体血液中の胎児細胞の富化と同定
US5629147A (en) * 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5641675A (en) 1994-10-07 1997-06-24 University Of Massachusetts Medical Center Cis-acting sequences for intracellular localization of RNA
US5783683A (en) * 1995-01-10 1998-07-21 Genta Inc. Antisense oligonucleotides which reduce expression of the FGFRI gene
US5741657A (en) * 1995-03-20 1998-04-21 The Regents Of The University Of California Fluorogenic substrates for β-lactamase and methods of use
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US20030215798A1 (en) * 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
US5866336A (en) * 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6361944B1 (en) * 1996-07-29 2002-03-26 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US7098320B1 (en) * 1996-07-29 2006-08-29 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6416959B1 (en) * 1997-02-27 2002-07-09 Kenneth Giuliano System for cell-based screening
US6750052B1 (en) * 1997-07-23 2004-06-15 The Brigham And Women's Hospital, Inc. Lens epithelial cell derived growth factor
WO1999011813A2 (en) * 1997-09-04 1999-03-11 Bayer Corporation Oligonucleotide probes bearing quenchable fluorescent labels, and methods of use thereof
US6485901B1 (en) * 1997-10-27 2002-11-26 Boston Probes, Inc. Methods, kits and compositions pertaining to linear beacons
WO1999037806A2 (en) * 1998-01-27 1999-07-29 Cytocell Limited Modified nucleic acid probes and uses thereof
DE69940196D1 (de) * 1998-04-15 2009-02-12 Hutchinson Fred Cancer Res Methoden und vektorenkonstrukte zur erzeugung von transgene nagetieren, welche ein heterologes gen ubiquitär exprimieren
JP4646404B2 (ja) * 1998-07-02 2011-03-09 ジェン−プローブ・インコーポレーテッド 分子トーチ（ｔｏｒｃｈ）
US6037130A (en) * 1998-07-28 2000-03-14 The Public Health Institute Of The City Of New York, Inc. Wavelength-shifting probes and primers and their use in assays and kits
US6203986B1 (en) 1998-10-22 2001-03-20 Robert H. Singer Visualization of RNA in living cells
AU1827200A (en) * 1998-11-25 2000-06-13 Isis Pharmaceuticals, Inc. (in situ) binary synthesis of biologically effective molecules
EP1151139A2 (en) * 1999-01-25 2001-11-07 UT-Battelle, LLC Multifunctional and multispectral biosensor devices and methods of use
WO2000062063A1 (en) * 1999-04-13 2000-10-19 Northwest Biotherapeutics, Inc. Methods for the diagnosis and treatment of metastatic prostate tumors
US6692965B1 (en) * 1999-11-23 2004-02-17 Chromocell Corporation Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
JP3460673B2 (ja) * 2000-02-04 2003-10-27 浜松ホトニクス株式会社 特定の遺伝子を発現した生細胞の選択的分離方法
EP1172445A1 (en) * 2000-07-14 2002-01-16 Praenadia GmbH A method for direct genetic analysis of target cells by using fluorescence probes
CA2423729A1 (en) * 2000-10-06 2002-04-11 Nugen Technologies, Inc. Methods and probes for detection and/or quantification of nucleic acid sequences
US6350580B1 (en) * 2000-10-11 2002-02-26 Stratagene Methods for detection of a target nucleic acid using a probe comprising secondary structure
US6861222B2 (en) * 2000-11-09 2005-03-01 Yale University Nucleic acid detection using structured probes
US20020129397A1 (en) * 2000-12-13 2002-09-12 Allen Keith D. Transgenic mice containing brain-specific membrane-anchored protein gene disruptions
EP1363994A2 (en) * 2000-12-22 2003-11-26 University Of Edinburgh Thymic epithelial progenitor cells and uses thereof
US20020090614A1 (en) 2001-01-09 2002-07-11 Jia Zhang Direct measurement method for gene expression using single chain antisense array
US7070933B2 (en) * 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
AU2002351233A1 (en) * 2001-12-04 2003-06-17 Genome Biosciences, Llc Gene targeting methods and vectors
AU2008212820B2 (en) * 2007-02-09 2014-01-30 Northwestern University Particles for detecting intracellular targets

Also Published As

Publication number Publication date
ATE541924T1 (de) 2012-02-15
HK1079238A1 (en) 2006-03-31
US20150143563A1 (en) 2015-05-21
DK2264165T3 (da) 2013-08-05
CA2496821C (en) 2012-06-19
EP1546327B1 (en) 2012-01-18
ES2423598T3 (es) 2013-09-23
EP1546327A4 (en) 2005-11-09
DK1546327T3 (da) 2012-03-26
US20100212040A1 (en) 2010-08-19
WO2004020625A1 (en) 2004-03-11
US20060147937A1 (en) 2006-07-06
JP4502808B2 (ja) 2010-07-14
KR101257500B1 (ko) 2013-04-23
EP1546327A1 (en) 2005-06-29
JP2005537005A (ja) 2005-12-08
EP2264165B1 (en) 2013-05-01
CA2496821A1 (en) 2004-03-11
CN1688693B (zh) 2010-12-22
EP2264165A3 (en) 2011-02-16
KR20050084810A (ko) 2005-08-29
MXPA05002192A (es) 2005-08-18
PT1546327E (pt) 2012-03-12
CN1688693A (zh) 2005-10-26
US6692965B1 (en) 2004-02-17
AU2002332768A1 (en) 2004-03-19
EP2264165A2 (en) 2010-12-22
ES2379731T3 (es) 2012-05-03
NZ538852A (en) 2006-03-31

Similar Documents

Publication Publication Date Title
EP2264165A3 (en) Selection and isolation of living cells using mRNA-binding probes
EP1476562A4 (en) OVEREXPRESSION OF EXTREMOZYME GENES IN PSEUDOMONAL BACTERIA AND CLOSELY BOUNDED BACTERIA
WO2003046173A1 (en) siRNA EXPRESSION SYSTEM AND PROCESS FOR PRODUCING FUNCTIONAL GENE-KNOCKDOWN CELLS AND THE LIKE USING THE SAME
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
GB0400584D0 (en) Nucleic acid chacterisation
WO2004061083A3 (en) Rna interference
WO2006006948A3 (en) METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
SG129236A1 (en) Somatic pluripotent cells
ES2255281T3 (es) Sobreexpresion de genes de fitasa en sistmas de levadura.
DK0691980T3 (da) 7-deazapurinmodifiderende oligonukleotider
GB0325653D0 (en) CST emulsions
WO2003066809A3 (en) Mismatch endonucleases and methods of use
AU2001268449A1 (en) Toxicity typing using liver stem cells
EP1017803A4 (en) EXPRESSION OF ENDOGENIC GENES BY HOMOLOGOUS RECOMBINATION OF A VECTOR CONSTRUCTURE WITH CELLULAR DNA
ATE354544T1 (de) Verhinderung des zellwachstums in einem gewässer
IL149791A0 (en) Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample
WO2004044164A3 (en) Method for identifying risk of melanoma and treatments thereof
AU2003287521A1 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
AU7614696A (en) Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
AU3162097A (en) Retinoid metabolizing protein
WO2004009843A3 (de) Nachweis von mikroorganismen
DE59812837D1 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
AU6667496A (en) A method and kit for evaluating the metastatic tendency of tumors
EP0823477A4 (en) METHOD FOR CHANGING PHOSPHOLIDE COMPOSITION TO A LIVING BODY AND RECOMBINANT VECTOR THEREFOR
WO2002016565A3 (en) Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes

Legal Events

Date Code Title Description
FF Patent granted
KB20 Patent renewed for 20 years